Dr. Derek Lowe is a highly respected figure in the pharmaceutical industry, known for his deep expertise in drug discovery and development. Derek got his BA from Hendrix College and his PhD in organic chemistry from Duke University on synthesis of natural products, before spending time in Germany on a Humboldt Fellowship. Dr. Lowe has made significant contributions to medicinal chemistry, working on various stages of drug research, from target identification to lead optimization. He has worked for both large pharmaceutical companies and smaller biotech firms, providing him with a broad perspective on the challenges and opportunities in the field. He is currently a Director at Novartis.
In addition to his professional work in the laboratory, Dr. Lowe is perhaps best known as the author of the popular blog In the Pipeline, which he has been writing since 2002. The blog offers insights into the world of drug discovery, covering scientific advances, industry trends, and the realities of pharmaceutical research. In the Pipeline has become a go-to resource for scientists, investors, and enthusiasts who seek to understand the complexities of drug development.
Dr. Lowe’s unique combination of hands-on experience in medicinal chemistry and his ability to communicate complex scientific ideas to a broad audience has made him a prominent voice in the scientific community. In our conversation, we discussed how he arrived at the position he currently holds, as well as how to think about academic science versus industry science. I continue to want to understand the similarities and differences between practicing these two types of science, and I believe Dr. Lowe gives a great pitch as to why one might want to become a scientist and how you can consider whether academics or industry may make more sense for you.
Useful Links:
Share this post